Authors:
BERG SL
MURRY DJ
MCCULLY CL
GODWIN K
BALIS FM
Citation: Sl. Berg et al., PHARMACOKINETICS OF O-6-BENZYLGUANINE AND ITS ACTIVE METABOLITE 8-OXO-O-6-BENZYLGUANINE IN PLASMA AND CEREBROSPINAL-FLUID AFTER INTRATHECALADMINISTRATION OF O-6-BENZYLGUANINE IN THE NONHUMAN PRIMATE, Clinical cancer research, 4(11), 1998, pp. 2891-2894
Authors:
MUELLER BU
ANDERSON BD
FARLEY MQ
MURPHY R
ZUCKERMAN J
JAROSINSKI P
GODWIN K
MCCULLY CL
MITSUYA H
PIZZO PA
BALIS FM
Citation: Bu. Mueller et al., PHARMACOKINETICS OF THE PROTEASE INHIBITOR KNI-272 IN PLASMA AND CEREBROSPINAL-FLUID IN NONHUMAN-PRIMATES AFTER INTRAVENOUS DOSING AND IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN AFTER INTRAVENOUS AND ORAL DOSING, Antimicrobial agents and chemotherapy, 42(7), 1998, pp. 1815-1818
Authors:
BLANEY SM
POPLACK DG
GODWIN K
MCCULLY CL
MURPHY R
BALIS FM
Citation: Sm. Blaney et al., EFFECT OF BODY POSITION ON VENTRICULAR CSF METHOTREXATE CONCENTRATIONFOLLOWING INTRALUMBAR ADMINISTRATION, Journal of clinical oncology, 13(1), 1995, pp. 177-179
Citation: Jd. Bacher et al., CEREBRAL SUBARACHNOID SAMPLING OF CEREBROSPINAL-FLUID IN THE RHESUS-MONKEY, Laboratory animal science, 44(2), 1994, pp. 148-152
Citation: Sl. Berg et al., PHARMACOKINETICS OF PEG-L-ASPARAGINASE AND PLASMA AND CEREBROSPINAL-FLUID L-ASPARAGINE CONCENTRATIONS IN THE RHESUS-MONKEY, Cancer chemotherapy and pharmacology, 32(4), 1993, pp. 310-314